Clinevo Technologies is an AI-powered SaaS company purpose-built for pharmacovigilance in life sciences. For over 10 years, Clinevo has supported 200+ pharma, biotech, and CRO clients across 13+ countries spanning North America, Europe, the Middle East, and Asia-Pacific, including the US, UK, India, Netherlands and more. Its client roster includes global names such as Novartis, Sun Pharma, Zydus, Dr. Reddy's, and Otsuka. Clinevo helps companies perform pharmacovigilance in a highly efficient, AI-driven, and cost-effective manner through its Integrated Drug Safety Platform, OnePV, which includes:
Safety database with AS2 gateway
Multi-channel case intake (MICC, web, and email)
Signal detection
Literature automation
SDEA / PV agreement management
To date, OnePV has processed 10 million+ safety cases, delivering up to 60% faster case processing and 50% lower PV operational costs. Clinevo's cloud-based software and databases have been validated by leading international authorities, including the USFDA, EMA, MHRA, and Health Canada, and meet global regulatory requirements including HIPAA, ICH, GxP, 21 CFR Part 11, Annex 11, and GDPR and delivering enterprise-grade pharmacovigilance without enterprise complexity or cost.